Epidemiology of Superficial Fungal Infections in Asia

  • Shivaprakash M. Rudramurthy
  • Dipika Shaw


Superficial fungal infections (SFIs) affect millions of people worldwide. The major causes of these infections include dermatophytes, non-dermatophyte molds (NDM), and yeasts. The etiological agents are restricted to stratum corneum. SFIs of importance include dermatophytosis, Malassezia associated infection, keratitis, and rare superficial fungal infection (tinea nigra and piedra). All the etiological agents have varied geographical distribution occurring in tropics where high humidity and hot climatic condition predominate. SFIs are also reported as epidemic infections in area of overcrowding and poor hygienic conditions. From the past two decades, the cases are increasingly being reported in patients undergoing transplants, chemotherapy and in immunocompromised patients. The epidemiology of SFIs in Asia is interesting as most of these regions have the climatic condition that supports the fungi to survive and proliferate.


  1. 1.
    Weitzman I, Summerbell RC. The dermatophytes. Clin Microbiol Rev. 1995;8:240–59.PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008;51:2–15.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Ajello L. Natural history of the dermatophytes and related fungi. Mycopathol Mycol Appl. 1974;53:93–110.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Ganeshkumar P, Sr M, Hemamalini M, Madhavan R, Lakshmanan A. Epidemiological and clinical pattern of dermatomycoses in rural India. Indian J Med Microbiol. 2015;33:134–6.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Khadka S, Sherchand JB, Pokharel DB, Pokhrel BM, Mishra SK, Dhital S, Rijal B. Clinicomycological characterization of superficial mycoses from a tertiary care hospital in Nepal. Dermatol Res Pract. 2016;2016:1–7.CrossRefGoogle Scholar
  6. 6.
    Hayette M-PP, Sacheli R. Dermatophytosis, trends in epidemiology and diagnostic approach. Curr Fungal Infect Rep. 2015;9:164–79.CrossRefGoogle Scholar
  7. 7.
    Majid I, Sheikh G, Kanth F, Hakak R. Relapse after oral terbinafine therapy in dermatophytosis: a clinical and mycological study. Indian J Dermatol. 2016;61:529–33.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Ahmed S, Jeelani S, Lanker A, Qayoom S, Sameem F. Relapse of cutaneous fungal infection in healthy individuals—a rising concern. Br J Med Med Res. 2016;11:1–8.Google Scholar
  9. 9.
    Sahoo AK, Mahajan R. Management of tinea corporis, tinea cruris, and tinea pedis: a comprehensive review. Indian Dermatol Online J. 2016;7:77–86.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Dogra S, Uprety S. The menace of chronic and recurrent dermatophytosis in India: is the problem deeper than we perceive? Indian Dermatol Online J. 2016;7:73–6.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Venkatesan G, Singh AJAR, Murugesan AG, Janaki C, Shankar SG. Trichophyton rubrum – the predominant etiological agent in human dermatophytoses in Chennai. India African J Microbiol Res. 2007;52:9–12.Google Scholar
  12. 12.
    Chakrabarti A, Sharma SC, Talwar P. Isolation of dermatophytes from clinically normal sites in patients with tinea cruris. Mycopathologia. 1992;120:139–41.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Rezaei-Matehkolaei A, Rafiei A, Makimura K, Gräser Y, Gharghani M, Sadeghi-Nejad B. Epidemiological aspects of dermatophytosis in Khuzestan, southwestern Iran, an update. Mycopathologia. 2016;181:547–53.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Balakumar S, Rajan S, Thirunalasundari T, Jeeva S. Epidemiology of dermatophytosis in and around Tiruchirapalli, Tamilnadu, India. Asian Pacific J Trop Dis. 2012;2:286–9.CrossRefGoogle Scholar
  15. 15.
    Garg A, Venkatesh V, Singh M, Pathak KP, Kaushal GP, Agrawal SK. Onychomycosis in central India: a clinicoetiologic correlation. Int J Dermatol. 2004;43:498–502.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Zhan P, Liu W. The changing face of dermatophytic infections worldwide. Mycopathologia. 2017;182:77–86.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Philpot CM. Geographical distribution of the dermatophytes: a review. J Hyg (Lond). 1978;80:301–13.CrossRefGoogle Scholar
  18. 18.
    Desai SC. Epidemic and clinical features of T. rubrum infections in the tropics. Int J Dermatol. 1966;5:222–4.CrossRefGoogle Scholar
  19. 19.
    Khan KA, Anwar AA. Study of 73 cases of tinea capitis and tinea favosa in adults and adolescents. J Invest Dermatol. 1968;51:474–7.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Bishnoi A, Vinay K, Dogra S. Emergence of recalcitrant dermatophytosis in India. Lancet Infect Dis. 2018;18:250–1.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Rudramurthy SM, Shankarnarayan SA, Dogra S, Shaw D, Mushtaq K, Paul RA, Narang T, Chakrabarti A. Mutation in the Squalene Epoxidase Gene of Trichophyton interdigitale and Trichophyton rubrum Associated with Allylamine Resistance. Antimicrob Agents Chemother. 2018;62:1–9.CrossRefGoogle Scholar
  22. 22.
    Martinez-Rossi NM, Peres NTA, Rossi A. Antifungal resistance mechanisms in dermatophytes. Mycopathologia. 2008;166:369–83.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Dogra S, Narang T. Emerging atypical and unusual presentations of dermatophytosis in India. Clin Dermatology Rev. 2017;1:12–8.CrossRefGoogle Scholar
  24. 24.
    Nenoff P, Verma SB, Vasani R, Burmester A, Hipler U-C, Wittig F, Krüger C, Nenoff K, Wiegand C, Saraswat A, Madhu R, Panda S, Das A, Kura M, Jain A, Koch D, Gräser Y, Uhrlaß S. The current Indian epidemic of superficial dermatophytosis due to Trichophyton mentagrophytes-A molecular study. Mycoses. 2019;62:336–56.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Verma S. Steroid modified tinea. BMJ. 2017;356:j973.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Verma S, Madhu R. The Great Indian epidemic of superficial dermatophytosis: an appraisal. Indian J Dermatol. 2017;62:227–36.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Naglot A, Shrimali DD, Nath BK, Gogoi HK, Veer V, Chander J, Tewari R, Centre C. Recent trends of dermatophytosis in northeast india ( assam ) and interpretation with published studies. IntJCurrMicrobiolAppSci. 2015;4:111–20.Google Scholar
  28. 28.
    Kashyap B, Bhalla P, Kaur R. A five-year survey of onychomycosis in New Delhi, India: Epidemiological and laboratory aspects. Indian J Dermatol. 2009;52:39–42.CrossRefGoogle Scholar
  29. 29.
    Lavanya V, Solabannavar SS. Prevalence and socio-economic correlation of dermatophytes isolated from clinical samples in a tertiary care centre in South India. Asian J AdvBasicSci. 2015;4:1–4.Google Scholar
  30. 30.
    Singal A, Rawat S, Bhattacharya SN, Mohanty S, Baruah MC. Clinico-myocological profile of tinea capitis in North India and response to griseofulvin. J Dermatol. 2001;28:22–6.PubMedCrossRefPubMedCentralGoogle Scholar
  31. 31.
    Sachin K, Seema B. Clinico-mycological profiles of dermatophytosis in Jaipur, India. African J Microbiol Res. 2016;10:1477–82.CrossRefGoogle Scholar
  32. 32.
    Bhatia VK, Sharma PC. Epidemiological studies on Dermatophytosis in human patients in Himachal Pradesh, India. Springerplus. 2014;3:134–40.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Mattei AS, Beber MA, Madrid IM, Souza Mattei A. Dermatophytosis in small animals. SOJ Microbiol Infect Dis. 2014;2:1–6.CrossRefGoogle Scholar
  34. 34.
    Upendra Y, Sendur S, Keswani N, Pallava A. Prevalence of dermatoses among the tribal children studying in residential schools of South Chhattisgarh, India. Indian J Paediatr Dermatology. 2018;19:15–20.CrossRefGoogle Scholar
  35. 35.
    Singh A, Masih A, Khurana A, Singh P, Kumar GM, Hagen F, Jacques FM, Chowdhary A. High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene. Mycoses. 2018;61:477–84.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Kannan P, Janaki C, Selvi GS. Prevalence of dermatophytes and other fungal agents isolated from clinical samples. Indian J Med Microbiol. 2006;24:212–5.PubMedPubMedCentralGoogle Scholar
  37. 37.
    Peerapur BV, Inamdar AC, Pushpa PV, Srikant B. Clinicomycological study of dermatophytosis in Bijapur. Indian J Med Microbiol. 2004;22:273–4.PubMedPubMedCentralGoogle Scholar
  38. 38.
    Kaur I, Thakur K, Sood A, Mahajan VK, Gupta PK. Clinico-mycological profile of clinically diagnosed cases of dertmatophytosis in North India- a prospective cross sectional study. IJHSR. 2016;6:54–60.Google Scholar
  39. 39.
    Pathania S, Rudramurthy SM, Narang T, Saikia UN, Dogra S. A prospective study of the epidemiological and clinical patterns of recurrent dermatophytosis at a tertiary care hospital in India. Indian J Dermatol Venereol Leprol. 2018;84:678–84.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Pathan N, Sharma R, Vyas L, Vyas A. A clinicomycological study of cutaneous mycoses in Sawai Man Singh Hospital of Jaipur, North India. Ann Med Health Sci Res. 2013;3:593–7.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Kaur I, Chaudhary A, Singh H. Clinico-microbiological aspects of tinea corporis in North India: emergence of Trichophyton tonsurans. Int J Res Dermatology. 2019;5:144–9.CrossRefGoogle Scholar
  42. 42.
    Maulingkar SV, Pinto MJW, Rodrigues S. A clinico-mycological study of dermatophytoses in Goa, India. Mycopathologia. 2014;178:297–301.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Sharma M, Sharma R. Profile of dermatophytic and other fungal infections in Jaipur. Indian J Microbiol. 2012;52:270–4.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Grover C, Arora P, Manchanda V. Tinea capitis in the pediatric population: A study from North India. Indian J Dermatol Venereol Leprol. 2010;76:527–32.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Cai W, Lu C, Li X, Zhang J, Zhan P, Xi L, Sun J, Yu X. Epidemiology of superficial fungal infections in Guangdong, Southern China: a retrospective study from 2004 to 2014. Mycopathologia. 2016;181:387–95.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Zhan P, Li D, Wang C, Sun J, Geng C, Xiong Z, Seyedmousavi S, Liu W, de Hoog GS. Epidemiological changes in tinea capitis over the sixty years of economic growth in China. Med Mycol. 2015;53:691–8.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Tao-Xiang N, Zhi-Cheng L, Sao-Mao W, Wen-Zhu L. Analysis of dermatomycoses in Lanzhou District of Northwestern China. Mycopathologia. 2005;160:281–4.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Ming PX, Ti YLX, Bulmer GS. Outbreak of Trichophyton verrucosum in China transmitted from cows to humans. Mycopathologia. 2006;161:225–8.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Deng S, Bulmer GS, Summerbell RC, De Hoog GS, Hui Y, Gräser Y. Changes in frequency of agents of tinea capitis in school children fromWestern China suggest slow migration rates in dermatophytes. Med Mycol. 2008;46:421–7.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Bassiri-Jahromi S, Khaksar A. Outbreak of tinea gladiatorum in wrestlers in Tehran (Iran). Indian J Dermatol. 2008;53:132–6.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Saham A, Mohammad H, Zomorodian K, Pakshir K, Badali H, Abdollah R, Ravandeh Mostafa SS. Molecular characterization and in vitro antifungal susceptibility of 316 clinical isolates of dermatophytes in Iran. Mycopathologia. 2016;181:89–95.CrossRefGoogle Scholar
  52. 52.
    Afshar P, Khodavaisy S, Kalhori S, Ghasemi M, Razavyoon T. Onychomycosis in North-East of Iran. Iran J Microbiol. 2014;6:98–103.PubMedPubMedCentralGoogle Scholar
  53. 53.
    Aghamirian MR, Ghiasian SA. A clinico-epidemiological study on tinea gladiatorum in Iranian wrestlers and mat contamination by dermatophytes. Mycoses. 2011;54:248–53.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Banik A, Durairaj E, Lyngdoh W, Khyriem AB, Sabhapandit D. Clinico-aetiologic profile of Onychomycoses in a tertiary care centre in northeast India. Trop Dr. 2018;48:136–42.CrossRefGoogle Scholar
  55. 55.
    Noguchi H, Hiruma M, Kawada A, Ishibashi A, Kono S. Tinea pedis in members of the Japanese Self-defence Forces: relationships of its prevalence and its severity with length of military service and width of interdigital spaces. Mycoses. 1995;38:494–9.PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    Noguchi H, Jinnin M, Miyata K, Hiruma M, Ihn H. Clinical features of 80 cases of tinea faciei treated at a rural clinic in Japan. Drug Discov Ther. 2014;8:245–8.PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Bhat YJ, Zeerak S, Kanth F, Yaseen A, Hassan I, Hakak R. Clinicoepidemiological and mycological study of tinea capitis in the pediatric population of Kashmir valley: a study from a tertiary care centre. Indian Dermatol Online J. 2017;8:100–3.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Yehia MA, El-Ammawi TS, Al-Mazidi KM, El-Ela MAA, Al-Ajmi HS. The spectrum of fungal infections with a special reference to dermatophytoses in the Capital area of Kuwait during 2000-2005: A retrospective analysis. Mycopathologia. 2010;169:241–6.PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Gupta AK, Mays RR, Versteeg SG, Piraccini BM, Takwale A, Shemer A, Babaev M, Grover C, Di Chiacchio NG, Taborda PRO, Taborda VBA, Shear NH, Piguet V, Tosti A. Global perspectives for the management of onychomycosis. Int J Dermatol. 2018:1–12.Google Scholar
  60. 60.
    Shahzad M, Alzolibani AA, Al Robaee AA, Bin Saif GA, Babikir IHK, Abdel-Magied EM, Elsayed AE. Onychomycosis in Qassim region of Saudi Arabia: A clinicoaetiologic correlation. J Clin Diagnostic Res. 2014;8:1–4.CrossRefGoogle Scholar
  61. 61.
    Gupta AK, Konnikov N, MacDonald P, Rich P, Rodger NW, Edmonds MW, McManus R, Summerbell RC. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol. 1998;139:665–71.PubMedCrossRefPubMedCentralGoogle Scholar
  62. 62.
    Aghamirian MR, Ghiasian SA. Onychomycosis in Iran: epidemiology, causative agents and clinical features. Japanese J Med Mycol. 2010;51:23–9.CrossRefGoogle Scholar
  63. 63.
    Borda LJ, Wikramanayake TC. Seborrheic dermatitis and dandruff: a comprehensive review. J Clin Investig dermatology. 2015;3Google Scholar
  64. 64.
    Otomi Cho AT. Molecular characterization of the skin fungal microbiota in patients with seborrheic dermatitis. J Clin Exp Dermatol Res. 2015;05:5–8.Google Scholar
  65. 65.
    Nakabayashi A, Sei Y, Guillot J. Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol. 2000;38:337–41.PubMedCrossRefPubMedCentralGoogle Scholar
  66. 66.
    Tajima M, Sugita T, Nishikawa A, Tsuboi R. Molecular analysis of Malassezia microflora in seborrheic dermatitis patients: comparison with other diseases and healthy subjects. J Invest Dermatol. 2008;128:345–51.PubMedCrossRefPubMedCentralGoogle Scholar
  67. 67.
    Jing W. A retrospective survey of mucocutaneous manifestations of HIV infection in Malaysia: analysis of 182 cases. J Dermatol. 2000;27:225–32.PubMedCrossRefPubMedCentralGoogle Scholar
  68. 68.
    Kim TG, Lee KH, Oh SH. Skin disorders in Korean patients infected with human immunodeficiency virus and their association with a CD4 lymphocyte count: a preliminary study. J Eur Acad Dermatology Venereol. 2010;24:1476–80.CrossRefGoogle Scholar
  69. 69.
    Wiwanitkit V. Prevalence of dermatological disorders in Thai HIV-infected patients correlated with different CD4 lymphocyte count statuses: a note on 120 cases. Int J Dermatol. 2004;43:265–8.PubMedCrossRefPubMedCentralGoogle Scholar
  70. 70.
    Rudramurthy SM, Honnavar P, Dogra S, Yegneswaran PP, Handa S, Chakrabarti A. Association of Malassezia species with dandruff. Indian J Med Res. 2014;139:431–7.PubMedPubMedCentralGoogle Scholar
  71. 71.
    Honnavar P, Prasad GS, Ghosh A, Dogra S, Handa S, Rudramurthy SM. Malassezia arunalokei sp. nov., a novel yeast species isolated from seborrheic dermatitis patients and healthy individuals from India. J Clin Microbiol. 2016;54:1826–34.PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Sunenshine PJ, Schwartz RA, Janniger CK. Tinea versicolor. Int J Dermatol. 1998;37:648–55.PubMedCrossRefPubMedCentralGoogle Scholar
  73. 73.
    Schwartz RA. Superficial fungal infections. Lancet. 2004;364:1173–82.PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Gupta AK, Bluhm R, Summerbell R. Pityriasis versicolor. J Eur Acad Dermatol Venereol. 2002;16:19–33.PubMedCrossRefPubMedCentralGoogle Scholar
  75. 75.
    Karray M, Mckinney WP. Tinea, versicolor pathophysiology treatment/management. StatPearls Publ. 2019:1–5.Google Scholar
  76. 76.
    Zeinali E, Sadeghi G, Yazdinia F, Shams-Ghahfarokhi M, Razzaghi-Abyaneh M. Clinical and epidemiological features of the genus malassezia in iran. Iran J Microbiol. 2014;6:354–60.PubMedPubMedCentralGoogle Scholar
  77. 77.
    Moallaei H, Namazi MJ, Bouchara JP, Pourhammed S. Malassezia species in students from universities of Sabzevar, Northeastern Iran. J Mycol Med. 2018;28:70–5.PubMedCrossRefPubMedCentralGoogle Scholar
  78. 78.
    He S, Du W, Yang S, Zhou S, Li W, Wang J, Xiao F, Xu S, Zhang X. The genetic epidemiology of tinea versicolor in China. Mycoses. 2008;51:55–62.PubMedPubMedCentralGoogle Scholar
  79. 79.
    Krisanty RIA, Bramono K, Made Wisnu I. Identification of Malassezia species from pityriasis versicolor in Indonesia and its relationship with clinical characteristics. Mycoses. 2009;52:257–62.PubMedCrossRefPubMedCentralGoogle Scholar
  80. 80.
    Vijayanand S. Characterization of Malassezia species isolated from Pityriasis versicolor patients and healthy subjects of North-east India by PCR-RFLP. Int J Recent Sci Res. 2017;8:16624–31.Google Scholar
  81. 81.
    Biswas Pramanik S, Chakraborty A, Nandi A, Banerjee M, Ghosh R, Bandopadhyay M, Banerjee D. A Study of Prevalence of Different Species of Malassezia Causing Pityriasis Versicolor and Sites of Distribution of Lesion in a Tertiary Care Hospital in Kolkata, India. IntJCurrMicrobiolAppSci. 2015;4:471–8.Google Scholar
  82. 82.
    Sharma A, Rabha D, Choraria S, Hazarika D, Ahmed G, Hazarika NK. Clinicomycological profile of pityriasis versicolor in Assam. Indian J Pathol Microbiol. 2016;59:159–65.PubMedCrossRefPubMedCentralGoogle Scholar
  83. 83.
    Chaudhary R, Singh S, Banerjee T, Tilak R. Prevalence of different Malassezia species in pityriasis versicolor in central India. Indian J Dermatol Venereol Leprol. 2010;76:159–64.PubMedCrossRefPubMedCentralGoogle Scholar
  84. 84.
    Kindo AJ, Sophia SKC, Kalyani J, Anandan S. Identification of Malassezia species. Indian J Med Microbiol. 2004;22:179–81.PubMedPubMedCentralGoogle Scholar
  85. 85.
    Prieto-Granada CN, Lobo AZC, Mihm MC. Skin infections. In: Diagnostic pathology of infectious disease. 1st ed. New York: Elsevier; 2010. p. 519–616.CrossRefGoogle Scholar
  86. 86.
    Akaza N, Akamatsu H, Sasaki Y, Kishi M, Mizutani H, Sano A, Hirokawa K, Nakata S, Nishijima S, Matsunaga K. Malassezia folliculitis is caused by cutaneous resident Malassezia species. Med Mycol. 2009;47:618–24.PubMedCrossRefPubMedCentralGoogle Scholar
  87. 87.
    Durdu M, Güran M, Ilkit M. Epidemiological characteristics of Malassezia folliculitis and use of the May-Grünwald-Giemsa stain to diagnose the infection. Diagn Microbiol Infect Dis. 2013;76:450–7.PubMedCrossRefPubMedCentralGoogle Scholar
  88. 88.
    Sutton DA, Rinaldi MG, Sanche SE. Dematiaceous fungi. Elsevier, 329–54; 2009.Google Scholar
  89. 89.
    Sarangi G, Dash D, Chayani N, Patjoshi S, Jena S. Bilateral tinea nigra of palm: a rare case report from Eastern India. Indian J Med Microbiol. 2014;32:86–8.PubMedCrossRefPubMedCentralGoogle Scholar
  90. 90.
    Tilak R, Singh S, Prakash P, Singh D, Gulati A. A case report of tinea nigra from North India. Indian J Dermatol Venereol Leprol. 2009;75:538.PubMedCrossRefPubMedCentralGoogle Scholar
  91. 91.
    Noguchi H, Hiruma M, Inoue Y, Miyata K, Tanaka M, Ihn H. Tinea nigra showing a parallel ridge pattern on dermoscopy. J Dermatol. 2015;42:518–20.PubMedCrossRefPubMedCentralGoogle Scholar
  92. 92.
    Chen GY, Cheng YW, Wang CY, Hsu TJ, Hsu ML, Yang PT, Chen WC. Prevalence of skin diseases among schoolchildren in Magong, Penghu, Taiwan: A community-based clinical survey. J Formos Med Assoc. 2008;107:21–9.PubMedCrossRefPubMedCentralGoogle Scholar
  93. 93.
    Shivaprakash MR, Singh G, Gupta P, Dhaliwal M, Kanwar AJ, Chakrabarti A. Extensive white piedra of the scalp caused by Trichosporon inkin: a case report and review of literature. Mycopathologia. 2011;172:481–6.PubMedCrossRefPubMedCentralGoogle Scholar
  94. 94.
    Khandpur S, Reddy BS. Itraconazole therapy for white piedra affecting scalp hair. J Am Acad Dermatol. 2002;47:415–8.PubMedCrossRefPubMedCentralGoogle Scholar
  95. 95.
    Al-Sogair SM, Moawad MK, Al-Humaidan YM. Fungal infection as a cause of skin disease in the Eastern Province of Saudi Arabia: prevailing fungi and pattern of infection. Mycoses. 2010;34:333–7.CrossRefGoogle Scholar
  96. 96.
    Kubec K, Dvorak R, Alsaleh QA. Trichosporosis (white piedra) in Kuwait. Int J Dermatol. 1998;37:186–7.PubMedCrossRefPubMedCentralGoogle Scholar
  97. 97.
    Adam BA, Soo-Hoo TS, Chong KC. Black piedra in west Malaysia. Australas J Dermatol. 1977;18:45–7.PubMedCrossRefPubMedCentralGoogle Scholar
  98. 98.
    Desai DH, Nadkarni NJ. Piedra: an ethnicity-related trichosis? Int J Dermatol. 2014;53:1008–11.PubMedCrossRefPubMedCentralGoogle Scholar
  99. 99.
    Venugopal PV, Venugopal TV. Superficial Mycoses in Saudi Arabia. Australas J Dermatol. 1992;33:45–8.PubMedCrossRefPubMedCentralGoogle Scholar
  100. 100.
    Thomas PA, Kaliamurthy J. Mycotic keratitis: epidemiology, diagnosis and management. Clin Microbiol Infect. 2013;19:210–20.PubMedCrossRefPubMedCentralGoogle Scholar
  101. 101.
    Radhakrishnan A (2011) Fungal Keratitis. 20–24.Google Scholar
  102. 102.
    Deorukhkar S, Katiyar R, Saini S. Epidemiological features and laboratory results of bacterial and fungal keratitis: A five-year study at a rural tertiary-care hospital in western Maharashtra, India. Singap Med J. 2012;53:264–7.Google Scholar
  103. 103.
    Bharathi MJ, Ramakrishnan R, Vasu S, Meenakshi R, Palaniappan R. Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A three-year study. Indian J Ophthalmol. 2003;51:315–21.PubMedPubMedCentralGoogle Scholar
  104. 104.
    Wang L, Sun S, Jing Y, Han L, Zhang H, Yue J. Spectrum of fungal keratitis in central China. Clin Exp Ophthalmol. 2009;37:763–71.PubMedCrossRefPubMedCentralGoogle Scholar
  105. 105.
    Thomas PA. Fungal infections of the cornea. Eye. 2003;17:852–62.PubMedCrossRefPubMedCentralGoogle Scholar
  106. 106.
    Ghosh AK, Gupta A, Rudramurthy SM, Paul S, Hallur VK, Chakrabarti A. Fungal keratitis in North India: spectrum of agents, risk factors and treatment. Mycopathologia. 2016;181:843–50.PubMedCrossRefPubMedCentralGoogle Scholar
  107. 107.
    Manikandan P, Abdel-hadi A, Randhir Babu Singh Y, Revathi R, Anita R, Banawas S, Bin Dukhyil AA, Alshehri B, Shobana CS, Panneer Selvam K, Narendran V. Fungal keratitis: epidemiology, rapid detection, and antifungal susceptibilities of fusarium and aspergillus isolates from corneal scrapings. Biomed Res Int. 2019;2019:1–9.CrossRefGoogle Scholar
  108. 108.
    Khanal B, Kaini KR, Deb M, Badhu B, Thakur SK. Microbial keratitis in eastern Nepal. Trop Dr. 2001;31:168–9.CrossRefGoogle Scholar
  109. 109.
    Dunlop AA, Wright ED, Howlader SA, Nazrul I, Husain R, McClellan K, Billson FA. Suppurative corneal ulceration in Bangladesh. A study of 142 cases examining the microbiological diagnosis, clinical and epidemiological features of bacterial and fungal keratitis. Aust N Z J Ophthalmol. 1994;22:105–10.PubMedCrossRefPubMedCentralGoogle Scholar
  110. 110.
    Xie L, Zhong W, Shi W, Sun S. Spectrum of Fungal Keratitis in North China. Ophthalmology. 2006;113:1943–8.PubMedCrossRefPubMedCentralGoogle Scholar
  111. 111.
    Hasika R, Lalitha P, Radhakrishnan N, Rameshkumar G, Prajna NV, Srinivasan M. Pythium keratitis in South India: Incidence, clinical profile, management, and treatment recommendation. Indian J Ophthalmol. 2019;67:42–7.PubMedPubMedCentralCrossRefGoogle Scholar
  112. 112.
    Thanathanee O, Enkvetchakul O, Rangsin R, Waraasawapati S, Samerpitak K, Suwan-apichon O. Outbreak of Pythium keratitis during rainy season: a case series. Cornea. 2013;32:199–204.PubMedCrossRefPubMedCentralGoogle Scholar
  113. 113.
    Lekhanont K, Chuckpaiwong V, Chongtrakool P, Aroonroch R, Vongthongsri A. Pythium insidiosum keratitis in contact lens wear: a case report. Cornea. 2009;28:1173–7.PubMedCrossRefPubMedCentralGoogle Scholar
  114. 114.
    Joseph J, Sridhar MS, Murthy S, Sharma S. Clinical and Microbiological Profile of Microsporidial Keratoconjunctivitis in Southern India. Ophthalmology. 2006;113:531–7.PubMedCrossRefPubMedCentralGoogle Scholar
  115. 115.
    Joseph J, Vemuganti GK, Sharma S. Microsporidia: emerging ocular pathogens. Indian J Med Microbiol. 2005;23:80–91.PubMedCrossRefPubMedCentralGoogle Scholar
  116. 116.
    Reddy AK, Balne PK, Garg P, Krishnaiah S. Is microsporidial keratitis a seasonal infection in India? Clin Microbiol Infect. 2011;17:1114–6.PubMedCrossRefPubMedCentralGoogle Scholar
  117. 117.
    Shivaprakash MR, Appannanavar SB, Dhaliwal M, Gupta A, Gupta S, Gupta A, Chakrabarti A. Colletotrichum truncatum: an unusual pathogen causing mycotic keratitis and endophthalmitis. J Clin Microbiol. 2011;49:2894–8.PubMedPubMedCentralCrossRefGoogle Scholar
  118. 118.
    Joseph J, Fernandes M, Sharma S. Colletotrichum dematium keratitis. J Postgrad Med. 2004;50:309–10.PubMedPubMedCentralGoogle Scholar
  119. 119.
    Mendiratta D, Thamke D, Shukla A, Narang P. Keratitis due to Colletotrichum dematium - a case report. Indian J Med Microbiol. 2005;23:56.PubMedCrossRefPubMedCentralGoogle Scholar
  120. 120.
    Ali SY, Gajjala SR, Raj A. Study of prevalence of dermatophytes among human immunodeficiency virus/AIDS patients in Shadan Institute of Medical Sciences and Teaching Hospital and Research Centre, Hyderabad, Telangana, India. Indian J Sex Transm Dis AIDS. 2018;39:98–101.PubMedPubMedCentralCrossRefGoogle Scholar
  121. 121.
    Sen A, Bhunia D, Datta PK, Ray A, Banerjee P. A study of onychomycosis at a tertiary care hospital in Eastern Bihar. Indian J Dermatol. 2018;63:141–6.PubMedPubMedCentralGoogle Scholar
  122. 122.
    Asifa N, Farhath K. Current mycological profile of onychomycosis in Kashmir valley: A hospital-based study. J Lab Physicians. 2017;9:190.PubMedPubMedCentralCrossRefGoogle Scholar
  123. 123.
    Dabas Y, Xess I, Singh G, Pandey M, Meena S. Molecular identification and antifungal susceptibility patterns of clinical dermatophytes following CLSI and EUCAST guidelines. J Fungi (Basel, Switzerland). 2017:3, 17–27.PubMedCentralCrossRefGoogle Scholar
  124. 124.
    Sharma R, Adhikari L, Sharma RL. Recurrent dermatophytosis: A rising problem in Sikkim, a Himalayan state of India. Indian J Pathol Microbiol. 2017;60:541–5.PubMedCrossRefPubMedCentralGoogle Scholar
  125. 125.
    Manjunath M. Clinicomycological study of Dermatomycosis in a tertiary care hospital. Indian J Microbiol Res. 2016;3:190–3.CrossRefGoogle Scholar
  126. 126.
    Kaur R, Panda PS, Sardana K, Khan S. Mycological pattern of dermatomycoses in a tertiary care hospital. J Trop Med. 2015;2015:1–5.CrossRefGoogle Scholar
  127. 127.
    Poluri LV, Indugula JP, Kondapaneni SL. Clinicomycological study of dermatophytosis in South India. J Lab Physicians. 2015;7:84–9.PubMedPubMedCentralCrossRefGoogle Scholar
  128. 128.
    Agarwal US, Saran J, Agarwal P. Clinico-mycological study of dermatophytes in a tertiary care centre in Northwest India. Indian J Dermatol Venereol Leprol. 2014;80:194–5.PubMedCrossRefPubMedCentralGoogle Scholar
  129. 129.
    Bhagra S, Ganju SA, Kanga A, Sharma NL, Guleria RC. Mycological pattern of dermatophytosis in and around shimla hills. Indian J Dermatol. 2014;59:268–70.PubMedPubMedCentralCrossRefGoogle Scholar
  130. 130.
    Surendran K, Bhat RM, Boloor R, Nandakishore B, Sukumar D. A clinical and mycological study of dermatophytic infections. Indian J Dermatol. 2014;59:262–7.PubMedPubMedCentralCrossRefGoogle Scholar
  131. 131.
    Yadav P, Singal A, Pandhi D, Das S. Clinicomycological study of dermatophyte toenail onychomycosis in New Delhi, India. Indian J Dermatol. 2015;60:153–8.PubMedPubMedCentralCrossRefGoogle Scholar
  132. 132.
    Kumari B, Randi K, Sharma R. The major etiological cause in human dermatophytoses in Chennai. Int J Mycol Plant Pathog. 2014;1:42–4.Google Scholar
  133. 133.
    Lone R, Bashir D, Ahmad S, Syed A, Khurshid S. A study on clinico-mycological profile, aetiological agents and diagnosis of onychomycosis at a government medical college hospital in kashmir. J Clin Diagn Res. 2013;7:1983–5.PubMedPubMedCentralGoogle Scholar
  134. 134.
    Pandey A, Pandey M. Isolation and characterization of dermatophytes with tinea infections at Gwalior (MP), India. Int J Pharm Sci Inven. 2013;2:5–8.Google Scholar
  135. 135.
    Niranjan HP, Padmaja PB. Study of onychomycosis at a tertiary care hospital in South India. J Evol Med Dent Sci. 2012;1:823–9.CrossRefGoogle Scholar
  136. 136.
    Sahai S, Mishra D. Change in spectrum of dermatophytes isolated from superficial mycoses cases: first report from Central India. Indian J Dermatol Venereol Leprol. 2011;77:335–6.PubMedCrossRefPubMedCentralGoogle Scholar
  137. 137.
    Patel P, Mulla S, Disha Patel GS. A Study of superficial mycosis in South Gujarat region. Natl J Community Med. 2010;1:85–8.CrossRefGoogle Scholar
  138. 138.
    Adhikari L, Das Gupta A, Pal R, Singh TSK, Das GA, Pal R, TSK S. Clinico-etiologic correlates of onychomycosis in Sikkim. Indian J Pathol Microbiol. 2009;52:194–7.PubMedCrossRefPubMedCentralGoogle Scholar
  139. 139.
    Wu SX, Guo NR, Li XF, Liao WQ, Chen M, Zhang QQ, Li CY, Li RY, Bulmer GS, Li DM, Xi LY, Lu S, Liu B, Zheng YC, Ran YP, Kuan YZ. Human pathogenic fungi in China-emerging trends from ongoing National Survey for 1986, 1996, and 2006. Mycopathologia. 2011;171:387–93.PubMedCrossRefPubMedCentralGoogle Scholar
  140. 140.
    Zhu M, Li L, Wang J, Zhang C, Kang K, Zhang Q. Tinea capitis in Southeastern China: A 16-year survey. Mycopathologia. 2010;169:235–9.PubMedCrossRefPubMedCentralGoogle Scholar
  141. 141.
    Abastabar M, Haghani I, Shokohi T, Hedayati MT, Aghili SR, Jedi A, Dadashi S, Shabanzadeh S, Hosseini T, Aslani N, Meis JF, Badali H. Low in vitro antifungal activity of tavaborole against yeasts and molds from onychomycosis. Antimicrob Agents Chemother. 2018;62:e01632–18.PubMedPubMedCentralGoogle Scholar
  142. 142.
    Farokhipor S, Ghiasian SA, Nazeri H, Kord M, Didehdar M. Characterizing the clinical isolates of dermatophytes in Hamadan city, Central west of Iran, using PCR-RLFP method. J Mycol Med. 2018;28:101–5.PubMedCrossRefPubMedCentralGoogle Scholar
  143. 143.
    Haghani I, Shams-Ghahfarokhi M, Dalimi Asl A, Shokohi T, Hedayati MT. Molecular identification and antifungal susceptibility of clinical fungal isolates from onychomycosis (uncommon and emerging species). Mycoses. 2019;62:128–43.PubMedCrossRefPubMedCentralGoogle Scholar
  144. 144.
    Babayani M, Salari S, Hashemi SJ, Ghasemi Nejad Almani P, Fattahi A. Onychomycosis due to dermatophytes species in Iran: Prevalence rates, causative agents, predisposing factors and diagnosis based on microscopic morphometric findings. J Mycol Med. 2018;28:45–50.PubMedCrossRefPubMedCentralGoogle Scholar
  145. 145.
    Khosravi AR, Shokri H, Vahedi G. Factors in etiology and predisposition of adult tinea capitis and review of published literature. Mycopathologia. 2016;181:371–8.PubMedCrossRefPubMedCentralGoogle Scholar
  146. 146.
    Chadeganipour M, Mohammadi R, Shadzi S. A 10-year study of dermatophytoses in Isfahan, Iran. J Clin Lab Anal. 2016;30:103–7.PubMedCrossRefPubMedCentralGoogle Scholar
  147. 147.
    Rashidian S, Falahati M, Kordbacheh P, Mahmoudi M, Safara M, Sadeghi Tafti H, Mahmoudi S, Zaini F. A study on etiologic agents and clinical manifestations of dermatophytosis in Yazd, Iran. Curr Med Mycol. 2015;1:20–5.PubMedPubMedCentralCrossRefGoogle Scholar
  148. 148.
    Naseri A, Fata A, Najafzadeh MJ, Shokri H. Surveillance of dermatophytosis in Northeast of Iran (Mashhad) and review of published studies. Mycopathologia. 2013;176:247–53.PubMedCrossRefPubMedCentralGoogle Scholar
  149. 149.
    Bassiri-Jahromi S. Epidemiological trends in zoophilic and geophilic fungi in Iran. Clin Exp Dermatol. 2013;38:13–9.PubMedCrossRefPubMedCentralGoogle Scholar
  150. 150.
    Ansar A, Farshchian M, Nazeri H, Ghiasian SA. Clinico-epidemiological and mycological aspects of tinea incognito in Iran: A 16-year study. Japanese J Med Mycol. 2011;52:25–32.CrossRefGoogle Scholar
  151. 151.
    Pang SM, Pang JYY, Fook-Chong S, Tan AL. Tinea unguium onychomycosis caused by dermatophytes: a ten-year (2005-2014) retrospective study in a tertiary hospital in Singapore. Singap Med J. 2018;59:524–7.CrossRefGoogle Scholar
  152. 152.
    Do NA, Nguyen TD, Nguyen KL, Le TA. Distribution of species of dermatophyte among patients at a dermatology Centre of Nghean Province, Vietnam, 2015–2016. Mycopathologia. 2017;182:1061–7.PubMedCrossRefPubMedCentralGoogle Scholar
  153. 153.
    Ramalingam R, Kunalan S, Tang MM. Mycology of onychomycosis: A 5-year retrospective review (2011 – 2015) in hospital Kuala Lumpur. Med J Malaysia. 2017;72:190–2.PubMedPubMedCentralGoogle Scholar
  154. 154.
    Nussipov Y, Markabayeva A, Gianfaldoni S, Tchernev G, Wollina U, Lotti J, Roccia MG, Fioranelli M, Lotti T. Clinical and epidemiological features of dermatophyte infections in Almaty, Kazakhstan. Open Access Maced J Med Sci. 2017;5:409.PubMedPubMedCentralCrossRefGoogle Scholar
  155. 155.
    Khaled JM, Golah HA, Khalel AS, Alharbi NS, Mothana RA. Dermatophyte and non dermatophyte fungi in Riyadh City, Saudi Arabia. Saudi J Biol Sci. 2015;22:604–9.PubMedPubMedCentralCrossRefGoogle Scholar
  156. 156.
    Elmegeed A, Al Shimaa M, Ouf S, Moussa A, Tarek AA, Eltahlawi SMR. Dermatophytes and other associated fungi in patients attending to some hospitals in Egypt. Braz J Microbiol. 1973;46:799–805.CrossRefGoogle Scholar
  157. 157.
    Abu Shaqra QM, Al Momani W. Cases of tinea capitis as encountered in a private practice laboratory from Jordan. J Mycol Med. 2011;21:24–7.PubMedCrossRefPubMedCentralGoogle Scholar
  158. 158.
    Akcaglar S, Ener B, Toker SC, Ediz B, Tunali S, Tore O. A comparative study of dermatophyte infections in Bursa, Turkey. Med Mycol. 2011;49:602–7.PubMedPubMedCentralGoogle Scholar
  159. 159.
    Koksal F, Er E, Samasti M. Causative agents of superficial mycoses in Istanbul, Turkey: retrospective study. Mycopathologia. 2009;168:117–23.PubMedCrossRefPubMedCentralGoogle Scholar
  160. 160.
    Narang T, Manhas A, Aggarwal P, Bala M, Kaur M, Gupte S. Study of the distribution of Malassezia species in patients with pityriasis versicolor and healthy individuals in Tertiary Care Hospital, Punjab. Indian J Med Microbiol. 2013;31:270.PubMedCrossRefPubMedCentralGoogle Scholar
  161. 161.
    Jena DK, Sengupta S, Dwari BC, Ram MK. Pityriasis versicolor in the pediatric age group. Indian J Dermatol Venereol Leprol. 2005;71:259–61.PubMedCrossRefPubMedCentralGoogle Scholar
  162. 162.
    Dutta S, Bajaj AK, Basu S, Dikshit A. Pityriasis versicolor: socioeconomic and clinico-mycologic study in India. Int J Dermatol. 2002;41:823–4.PubMedCrossRefPubMedCentralGoogle Scholar
  163. 163.
    Zhang H, Ran Y, Xie Z, Zhang R. Identification of malassezia species in patients with seborrheic dermatitis in China. Mycopathologia. 2013;175:83–9.PubMedCrossRefPubMedCentralGoogle Scholar
  164. 164.
    Mansouri P, Farshi S, Hashemi J, Khosravi AR, Saghazadeh M. Identification of Malassezia species isolated from patients with seborrheic dermatitis, atopic dermatitis, and normal subjects. J Mycol Med. 2010;20:279–82.CrossRefGoogle Scholar
  165. 165.
    Rasi A, Naderi R, Behzadi AH, Falahati M, Farehyar S, Honarbakhsh Y, Akasheh AP. Malassezia yeast species isolated from Iranian patients with pityriasis versicolor in a prospective study. Mycoses. 2010;53:350–5.PubMedPubMedCentralGoogle Scholar
  166. 166.
    Tarazooie B, Kordbacheh P, Zaini F, Zomorodian K, Saadat F, Zeraati H, Hallaji Z, Rezaie S. Study of the distribution of Malassezia species in patients with pityriasis versicolor and healthy individuals in Tehran, Iran. BMC Dermatol. 2004;4:5.PubMedPubMedCentralCrossRefGoogle Scholar
  167. 167.
    Lyakhovitsky A, Shemer A, Amichai B. Molecular analysis of Malassezia species isolated from Israeli patients with pityriasis versicolor. Int J Dermatol. 2013;52:231–3.PubMedCrossRefPubMedCentralGoogle Scholar
  168. 168.
    Rodoplu G, Saracli MA, Gümral R, Taner Yildiran S. Distribution of Malassezia species in patients with pityriasis versicolor in Turkey. J Mycol Med. 2014;24:117–23.PubMedCrossRefPubMedCentralGoogle Scholar
  169. 169.
    Karakaş M, Turaç-Biçer A, Ilkit M, Durdu M, Seydaǒlu G. Epidemiology of pityriasis versicolor in adana, Turkey. J Dermatol. 2009;36:377–82.PubMedCrossRefPubMedCentralGoogle Scholar
  170. 170.
    Kamalam A, Thambiah AS. A study of 3891 cases of mycoses in the tropics. Sabouraudia. 1976;14:129–48.PubMedCrossRefPubMedCentralGoogle Scholar
  171. 171.
    Kiken DA, Sekaran A, Antaya RJ, Davis A, Imaeda S, Silverberg NB. White piedra in children. J Am Acad Dermatol. 2006;55:956–61.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  • Shivaprakash M. Rudramurthy
    • 1
  • Dipika Shaw
    • 1
  1. 1.Department of Medical MicrobiologyPostgraduate Institute of Medical Education and Research (PGIMER)ChandigarhIndia

Personalised recommendations